Contact Us Report about mistake Sign In Help

Compare

Clinical pharmacology

Language of instruction

lithuanian

Qualification degree and (or) qualification to be awarded

MD in clinical pharmacology

Place of delivery

Kaunas, A. Mickevičiaus g. 9, LT-44307

Institution that has carried out assessment

No data

Institution that has performed accreditation, accreditation term

Studijų kokybės vertinimo centras, 8/31/2020

Data provided or updated (date)

8/1/2014

Order on accreditation

SV6-13
More about programme

Institutions providing this programme

Programmes with similar name

Programmes granting same qualifications

Summary of the Profile

Objective(s) of a study programme:
To develope a skilled specialized doctor, who is broadly educated, ethical, and creative, interested in the news of the science. This person is able to work in team and solve arising problems, cherishes democracy.
The specialized doctor would have professional qualification of clinical pharmacologist and would be able to apply the knowledge he/she received in practical work.
Learning outcomes:
After completing the Clinical pharmacology residency program, a person:
1. Will be an honest and respectable with patients, who have drug induced or other pharmacotherapeutical problems, will be able to protect patients’ interests in rational drug use, will obey to the norms of ethichs of medicine, will follow good clinical practise regulations, will defend public interest on rational drug use,
2. Will be able to evaluate his/hers competences in clinical pharmacology and related medical specialties (including public health), will be able to ask for help, solve new pharmacotherapeutical problems and adopt to new situations, solve problems and make decisions, work in a team,
3. Will be able to analyze features of rational drug use, also analyze evidence of drug induced health problems, understand desirable and not desirable effects of drugs on one’s health, plan and prosecute scientific trials, to consult about the use of pharmacological therapy in case of non-authorised provisions, able to analyze public factors, influencing rational drug use,
4. Will be able to do a clinical examination, interpret symptoms, which might be drug induced and differentiate those from non-drug induced symptoms, able to understand drug interactions, evaluate the level of interaction, make a diagnostic and treatment plan on pharmacotherapeutic risks, able to interpret the results, able to make a differential diagnosis, evaluate the effectiveness of assigned treatment,
5. Will be able to interpret results of diagnostic investigations, and their necessity, prosecute clinical pharmacokinetic, pharmacodynamic effectiveness studies, safety and economical studies, understand predicate and prognostic features of the use of drug and evaluate their analysis methods,
6. Will be able to provide urgent medical help,
7. Will undertand and will promote healthy life style, will recommend ratinal drug use, will solve pharmacotherapeutical problems associated with public health.
8. Will be able to plan and prosecute clinical pharmacokinetical, pharmacodynamical, safety, effectiveness and pharmacoeconomical studies and interpret the results, will be able to evaluate and associate the results with the data from drugs’ development studies.
Activities of teaching and learning:
Lectures, seminars, individual work with patiens and practical work in hospitals, public institutions, laboratories, research institutes
Methods of assessment of learning achievements:
The resident is evaluated during each learning module, the description of each learning module includes the minimal amount of different clinical skills resident must demonstrate during the module. If the resident does not reach the required number, he/she cannot attend the theoretical exam. Final grade of the module is combined of 50% of the grade the resident received for the practical skills and 50% of the theoretical knowledge evaluation.
The final grade of the whole residency program in combined of:
Result of the final exam – 80%
Evaluation of each module – 10%
Evaluation of the Graduation thesis – 10%
Framework:
Study subjects (modules), practical training:
Basics of Pulmonology, Allergology and Immunology, Basics of Cardiology, Basics of Gastroenterology, Basics of Rheumatology, Basics of Nephrology, Basics of Hemathology, Basics of Endocrinology, Basics of Oncology, Emergency medicine, Basics of Intensive care, News of Basic Pharmacology and Basics of Clinical Pharmacology, Basics of Drug Development, Clinical trials on drugs’ pharmacokinetics, pharmacodynamics, efficacy and safety, Clinical Pharmacology in Internal Medicine, Clinical Pharmacology in Pshychiatry, Neurology, Mothers’ and childs’ Clinical Pharmacology, Clinical Pharmacology in Geriatrics, General Practise, Clinical Pharmacology in Surgery, Radiology, and Laboratory medicine
Specializations:
--
Optional courses:
Chosen during 3rd or 4th year of studies.
Distinctive features of a study programme:
The physician clinical pharmacologists not only learn to investigate the patient and prescribe drugs but also study into the segments of personal and public health sectors, where effcicacy and safety is evaluated for the certain drug, rational and evident based drug use is sought, pharmacotherapeutic problems are managed. Physician clinical pharmacologist has clinical skills not only for recognition of adverse drug reaction or interaction but also able to monitor the drugs as technology usage at the level of individual patient as well as of pulbic. The specialist will be able to share the information the is independent from the developer of the technology. This specialist will be able to intitate the development of new drugs or active substances, initiate and perform the non-clinical and together with specialists clinical phase one and two studies. Very important part of his competence is the preparation of new specialists in this area.